Eric Rothe serves as Executive at Greenwich LifeSciences, Inc., where they oversee executive responsibilities. Since joining the company, Eric Rothe has executed 1 insider transactions totaling $10.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 20, 2020 involved purchasing 2,000 shares valued at $10.8K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 20, 2020 | GLSI | $10.8K | Purchase | 2,000 | $5.40 | Discretionary |
Eric Rothe currently holds 313,226 shares of Greenwich LifeSciences, Inc. (GLSI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Rothe has been a net buyer of GLSI stock. They have purchased $10.8K and sold $0 worth of shares.
Eric Rothe's most recent insider trade was on Nov 20, 2020, when they purchased 2,000 shares at $5.40 per share.
Get notified when new Form 4 filings are submitted